BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaxcellbio And Reber Genetics Form Strategic Partnership To Expand Companion Animal Immunotherapy Across Asia

Vaxcellbio (CEO Je-Jung Lee, MD, PhD), a leading immuno-oncology company, announced on Wednesday that it has signed a Master Partnership Agreement (MPA) wi...

March 12, 2026 | News

QIAGEN Study Shows QuantiFERON TB Gold Plus Improves Cost Effectiveness Of HIV TB Screening In Thailand

Peer-reviewed health-economic analysis evaluates tuberculosis infection (TBI) screening strategies among people living with HIV in Thailand Quanti...

February 13, 2026 | News

HD And Pacific Prime Form Strategic Partnership To Expand AI Enabled Healthcare Access In Southeast Asia

Strategic partnership expands access to hybrid healthcare models through AI-driven navigation, connecting Pacific Prime clients to HDmall, HDcare, and Ji...

January 22, 2026 | News

Formosa Pharmaceuticals Grants Exclusive ASEAN Rights For APP13007 To Rxilient Medical

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Rxil...

December 04, 2025 | News

Hasten Biopharmaceutical Completes 70 Marketing Authorization Transfers and Builds End-to-End Commercial Network Across Asia-Pacific

Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific pro...

November 05, 2025 | News

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown

The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...

October 08, 2025 | Analysis

eXmoor Pharma and Siam Bioscience Partner to Build Southeast Asia’s Premier Cell and Gene Therapy Hub

eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company in A...

September 24, 2025 | News

Chulalongkorn University Launches ER-VIPE, a VR Training Platform to Transform Emergency Care in Thailand

Because every minute in the emergency room matters, the Chulalongkorn University Design for Society Center (CUD4S), in collaboration with the Department of...

August 29, 2025 | News

Abbott Secures Thailand Approval For Denosumab Biosimilar Expanding Access To Osteoporosis Treatment

Abbott denosumab biosimilar has received regulatory approval in Thailand, expanding access to advanced therapies for osteoporosis and cancer-related bone l...

August 27, 2025 | News

DKSH Healthcare Pioneers Scope 3 Carbon Emissions Tracking and Reusable Cold-Chain Packaging in Thailand

DKSH Business Unit Healthcare has achieved a significant milestone in advancing sustainable healthcare supply chains by successfully measuring Scope 3 carb...

August 20, 2025 | News

South Korea’s GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Plasma-Derived Medicines Workforce in Thailand

GC Biopharma , a South Korean biopharmaceutical company, announced that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Soc...

August 19, 2025 | News

DKSH Seals Strategic Acquisition of Eppendorf’s Direct Business in Thailand

DKSH has announced that it signed an agreement to acquire Eppendorf’s direct business in Thailand. Eppendorf is a leading interna...

July 21, 2025 | News

DKSH Partners with Bayer to Expand Access to Cardiovascular and Women’s Health Products Across Southeast Asia

DKSH has signed a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of t...

July 10, 2025 | News

Stay Connected